IPO News Archive

Texas Instruments spin-off Sensata Technologies unveils IPO terms

2/26/10


Sensata Technologies, which develops, manufactures, and sells sensors and controls for mission critical applications, announced terms for its upcoming IPO on Friday. Sensata Technologies first began as General Plate Company in 1916 and has since undergone various mergers, including one with Texas Instruments in 1959. In April of 2006, the business was sold to Bain Capital and became a stand-alone entity. The Netherlands-based company plans to raise $600 million by offering 31.6 million shares at $18-$20, with 17% coming from insiders; at the midpoint of the proposed range, Sensata will command a market value of $3.4 billion. The company booked $1.1 billion in sales for 2009, down 20% (from $1.4 billion) from the previous year. However, Sensata claims it stands to benefit from the improving environment and reported $338 million in sales for the fourth quarter of 2009, up 26% from the year ago period (from $268 million). Sensata Technologies plans to list on the NASDAQ with Morgan Stanley, Barclays Capital and Goldman Sachs acting as the lead underwriters on the deal. Pricing is scheduled for Wednesday, Mar. 10.

View IPO Profile: ST         
Related Links: Upcoming IPOs
Source: www.RenaissanceCapital.com
Latest User Comments
>>>>>> C <<<<<< BUY >>>>> 420 <<<<<<<< 3/11/2010 4:35:16 PM
Posted by: Starttra
&&&&&&&&& HOLD $$$$$$$$$$$$$...
Re - A Good Deal for Public Investors? 3/9/2010 12:55:54 PM
Posted by: dcoyle
What, you mean like Vonage?...
A good deal for public investors? 3/8/2010 8:06:44 PM
Posted by: polopony
If it''s good for Bain Capital, will it be good for public investors...
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the IPO Plus Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in the IPO Plus Fund
About Fund Prospectus Invest